How much does a complete course of momelotinib cost?

Momelotinib (momelotinib) has not yet been officially launched in China. If patients need to use this drug, they usually need to purchase it through regular overseas channels. Since molotinib is an important targeted drug for the treatment of blood system diseases such as myelofibrosis, it is relatively expensive, especially the original version, which puts a certain amount of financial pressure on patients.

According to the latest price information, the cost of the original version of molotinib in the United States is very high. Generally, the price of a complete course of treatment may reach more than 200,000 yuan. This price reflects the high cost of R&D and production of original drugs, as well as the scarcity and exclusivity of targeted therapy drugs in the market. For patients with limited financial conditions, such costs are undoubtedly a greater burden.

In contrast, the generic version of molotinib produced by Lucius Pharmaceuticals has been approved by the Lao Ministry of Health for marketing. Its drug ingredients are basically the same as the original drug, but the price is greatly reduced. Taking 100mg*30 tablets as an example, the latest price is only about 2,000 yuan. The emergence of generic drugs provides more patients with affordable options and helps alleviate barriers to medication use caused by the prohibitive cost of treatment.

In summary, the cost of a complete course of molotinib varies greatly, mainly depending on the version of the drug purchased. Although original drugs are more expensive, the emergence of generic drugs has made effective treatment available to more patients. Patients should consider their own financial situation and doctor's advice when choosing, and plan a reasonable treatment plan to ensure efficacy and sustainable medication economy.

Reference materials:https://en.wikipedia.org/wiki/Momelotinib